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Abstract
Background: There is an established relationship between depression and sexual functioning
in women. However, there is limited research examining the relationship between perinatal
depression and sexual functioning.
Methods: This study draws on the Mercy Pregnancy and Emotional Wellbeing Study and
reports on 211 women recruited in early pregnancy and followed to 12 months postpartum.
Woman were assessed for depression using the Structured Clinical Interview for the DSM-IV,
repeated measurement of depressive symptoms using the Edinburgh Postnatal Depression
Scale (EPDS) and sexual functioning using the Female Sexual Functioning Inventory (FSFI).
Data was also collected on antidepressant use, mode of delivery, history of childhood trauma,
breastfeeding and partner support.
Results: Women showed a decline in sexual functioning over pregnancy and the first 6 months
postpartum, which recovered by 12 months. For women with depression sexual functioning
was lower throughout pregnancy and continued to be lower at six months postpartum than
those without depression. Ongoing depressive symptoms at 12 months were also associated
with lower sexual functioning. Sexual functioning was not predicted by mode of delivery,
antidepressant use or childhood trauma. Breastfeeding predicted lower sexual functioning only
at 6 months. Higher partner support predicted higher female sexual functioning.
Conclusion: Pregnancy and the postpartum are a time of reduced sexual functioning for
women; however, women with depression are more likely to have lower levels of sexual
functioning and this was not predicted by antidepressant use. In women with perinatal
depression, consideration of the impact on sexual functioning should be an integral part of care.
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Background
Pregnancy and the postpartum period is a time of significant change for women
physically, socially and psychologically. For couples, the transition to becoming parents to a
new baby can be challenging and this transition may influence many aspects of their
relationship including their sexual relationship. A woman’s sexual functioning is part of her
psychosocial wellbeing and understanding the influences including in pregnancy and the
postpartum is important aspect of her clinical care.
Sexual functioning in women is known to be influenced by health conditions, social
and cultural expectations, and mental health such as depression. Experiences of trauma in
childhood, such as childhood sexual abuse, has been associated with both increased risk of
depression and of sexual dysfunction (DiLillo, 2001, Heim et al., 2008). During pregnancy
and the postpartum, factors such as mode of delivery, breastfeeding and partner support have
also been identified as potential influences on sexual function (McBride and Kwee, 2017,
Saberi et al., 2017, Serati et al., 2010, Song et al., 2014).
A recent comprehensive review of pregnancy and sexual function failed to find strong
evidence for a single factor to explain changes in sexual functioning across the perinatal
period (Yeniel and Petri, 2014). This included a clear association with personal or
relationship dissatisfaction. Overall, this review found a reported decrease in sexual
functioning across pregnancy and a gradual improvement by six months postpartum. This
may reflect the expected impact physically and psychosocially of pregnancy and early
parenting on sexual functioning and an improvement in sexual functioning in sync with
physical recovery and adjustment to the demands of parenthood. Priorities for couples may be
managing the impact of pregnancy and the demands of early parenting rather than their
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sexual relationship. However, within this review of 20 identified studies, only one examined
depression as a risk factor for poorer sexual functioning.

While outside of the perinatal period, depression in women has been associated with
lower sexual functioning and antidepressant medication can further reduce interest in sexual
behavior (Cyranowski et al., 2004, Fabre and Smith, 2012). Within pregnancy, there have
been no studies to our knowledge that have examined both depression and antidepressant use
and sexual functioning. For women making decisions about treatment for depression in
pregnancy understanding any effect from antidepressants on aspects of wellbeing including
sexual functioning may be important information.
The limited studies that have examined depression and sexual functioning in
pregnancy have either relied on depression symptom screening measures, only measured
depression at one timepoint or not consistently accounted for other important variables
(Asselmann et al., 2016, De Souza et al., 2015, Giallo et al., 2017, Saberi et al., 2017,
Wallwiener et al., 2017). Despite these limitations, these studies have found a consistent
relationship between depression and reduced sexual function across the perinatal period.
We build on this previous reported research to understand the relationship between
perinatal depression and sexual functioning by examining longitudinal data from early
pregnancy to 12 months postpartum. In addition, we use both a diagnostic measure of
depression as well as repeat measurement of sexual functioning and depressive symptoms
and a range of covariates potentially associated sexual functioning. These include
antidepressant use, mode of delivery, childhood trauma, breastfeeding and partner support.
Methods
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This study used data obtained by the Mercy Pregnancy and Emotional Wellbeing
Study (MPEWS), which has a pregnancy cohort design (Galbally et al., 2017). Inclusion
criteria for participants were being less than 20 weeks pregnant and proficient in English.
Exclusion criteria included bipolar or psychotic disorders, substance abuse disorder, child
protection involvement, intellectual disability, serious pre-existing physical illness and
psychiatric illness requiring current acute inpatient admission. Women who developed
pregnancy complications were not excluded. The cohort was comparable to Australian
national averages on key pregnancy and birth variables (Galbally et al., 2017). MPEWS
recruitment was initially through the antenatal booking-in process and began in September
2012 with the last participant giving birth in May 2015. Data were collected via self-report
questionnaires distributed by the study’s research coordinator at the following waves: early
pregnancy (Wave 1), third trimester (Wave 2), birth (Wave 3), six months postpartum (Wave
4), and 12 months postpartum (Wave 5). Mercy Health Human Research Ethics Committee
approved this study and all participants provided written informed consent to participate.
Participants
For this study, participants were a sub-sample of 211 pregnant women. Not included
in this study were women who reported not engaging in sexual activity during the perinatal
period (i.e., early pregnancy through 12 months postpartum), women without at least one
prenatal FSFI scores (i.e., early pregnancy or third trimester), and women without at least one
postnatal FSFI scores (i.e., six or 12 months postpartum).
The decision to treat as missing women who reported no sexual activity was guided
by recommendations made by Meyer-Bahlburg and Dolezal’s (2007) critique of the FSFI
where to include these women would inflate rates of sexual dysfunction. All 211 women
remained eligible at each wave and were approached for follow-up. At the third trimester,
210 out of the 211 women completed follow-up, with 204 completing follow-up at six
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months postpartum, and 196 completing follow-up at 12 months postpartum. Further
information on these excluded participants is available in Supplementary File.
Measures
Female Sexual Function
Sexual function was measured using the 6-item version of the Female Sexual
Function Index (FSFI) (Isidori et al., 2010, Rosen, 2000) in early pregnancy (< 20 weeks
gestation) and third trimester of pregnancy and 6 and 12 months postpartum (Waves 1, 2, 4
and 5). The FSFI is a psychometrically validated self-report tool for measuring female sexual
functioning developed by Rosen et al. (Rosen, 2000). The 6-item version of the FSFI was
developed as a rapid screening measure female sexual functioning. Each of the items
represents one of the six dimensions of female sexual function (desire, arousal, lubrication,
orgasm, satisfaction and pain). Higher scores indicate better sexual function (Isidori et al.,
2010, Rosen, 2000).
Maternal Mental Health
A diagnostic measure was undertaken at recruitment in early pregnancy: The
Structured Clinical Interview for DSM-IV (SCID-IV), Mood Disorders Schedule (First et al.,
1997). Depressive symptoms were measured using the Edinburgh Postnatal Depression Scale
(EPDS) (Cox et al., 1987), which is a 10-item self-report tool designed to detect symptoms of
depression in perinatal women. The EPDS was administered in early pregnancy and third
trimester of pregnancy and 6 and 12 months postpartum (Waves 1, 2, 4 and 5). The scale has
been validated for use with Australian women during the perinatal period, where sensitivity
and specificity for cut-off scores of 12.5 and 13.5 were 100 and 95.7 per cent, respectively
(Boyce et al., 1993).
Anxiety symptoms were measured using the state anxiety subscale from the StateTrait Anxiety Inventory (STAI, Y-form; Speilberger et al., 1983) at the third trimester, and at
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six and 12 months postpartum. The inventory measures situational anxiety symptoms using
20 items, each scored using a 1 (Not at all) to 4 (Very much so) Likert scale. The sum of the
items range between 20 and 80 indicating the magnitude of situational anxiety reported by the
participant at the point in time of completion, with higher scores indicating more state
anxiety. Internal consistency of the STAI state scale was strong at each measurement in our
data, with Cronbach’s alphas ranging .93 to .94.
Covariates of Sexual Function
Antidepressant Use: Antidepressant use was assessed by self–report at recruitment
during the early pregnancy trimester (0 = no antidepressant use; 1 = antidepressant use).
While not utilised in this report use was also reported in third trimester and confirmed in
pregnancy within hospital records. Both agent and dose was recorded at each time point.
Maternal blood and cord blood was collected at delivery and drug levels undertaken to
confirm exposure, these levels were not used for this report (Galbally et al., 2017).
Mode of delivery: (0 = vaginal birth, including assisted; 1 = caesarean section) were
extracted from participants’ records and coded.
Breastfeeding: At six and 12 months postpartum, women self-reported whether they
were breastfeeding (1) or not breastfeeding (0).
Childhood trauma: Participants completed the short-form Childhood Trauma
Questionnaire (CTQ-SF) (Bernstein et al., 2003) to screen for histories of maltreatment. The
instrument includes 28 items covering five dimensions of trauma: emotional, physical, and
sexual abuse, and emotional, and physical neglect. Three items can be used to gauge
participants’ minimisation of their experiences. We used the total score of the remaining 25
items to indicate a continuous measure of experiences with childhood trauma. Scores ranged
between 25 and 76, where higher scores denote more extreme trauma. The CTQ had been
clinically validated and demonstrates strong internal consistency (Bernstein et al., 2003). .

8
Partner Social Support: To assess perceived effectiveness of partner social support,
participants completed The Social Support Effectiveness questionnaire (Rini et al., 2006),
which asks the respondent to evaluate the quantity and quality of the support provided by her
partner. We used two of the four subscales from the SSE, Task Support, and Emotional
Support, comprising five items each. Both subscales have demonstrated acceptable reliability
(Cronbach’s α = .75 to .87).
Data Analysis
The initial analyses were conducted using SPSS version 24(IBM Corp., 2016). We
present average FSFI scores for each Wave and test depression diagnosis as a betweengroups effect within each point in time using Analysis of Variance tests. Where variances
between the depression groups were heterogeneous, as indicated by a significant Levene’s
test, we conducted the Welch’s F test. We then conducted a series of bivariate correlations
between key covariates of female sexual functioning in the literature with FSFI scores at each
Wave. One covariate, the total score for the CTQ, was significantly skewed, and so a natural
logarithmic transformation was applied to improve the distribution. Although this improved
the distribution of the total CTQ, the variable remained significantly skewed; as a result, nonparametric Spearman’s rho coefficients were conducted between FSFI for each Wave and the
log-transformed total CTQ.
Longitudinal modelling was conducted using Mplus 7(Muthén and Muthén, 19982012). Missing data due to attrition or incomplete surveys were handled using maximum
likelihood estimation and models was estimated using maximum likelihood with robust
standard errors (MLR) due to multivariate non-normality in the data. A latent growth curve
model was used to test several time-invariant and time-variant covariates of FSFI change
during the perinatal period. To determine an appropriate model of change in FSFI, we used a
sequential approach to growth modelling (Bollen and Curran, 2006). First, we compared
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models of growth for FSFI (i.e., intercept only, linear slope, and quadratic growth) using the
four waves of data. Appropriate model fit was determined based on the Chi-square test (p <
.05), and fit indices, Root Mean Square Error of Approximation (RMSEA ≤ .05) and
Standardised Root Mean Square Residual (SRMR ≤ .08)(Hu and Bentler, 1999). The best
fitting model of growth was determined using the Satorra-Bentler Chi-Square Difference
test(Satorra and Bentler, 2010). We then examined the effects of the time-invariant
covariates, diagnosed depression, antidepressant use and childhood trauma, on female sexual
functioning starting values and change factors during the perinatal period. Next, we examined
contemporaneous effects of depressive symptoms, and perceived emotional and task support
effectiveness (time-varying covariates) on female sexual functioning at the third trimester,
and six and 12 months post-partum. These time-varying covariates allowed for modelling of
change in female sexual functioning, net of the cross-sectional effects of depressive
symptoms and social support effectiveness during the perinatal period. Time-varying
covariates were grand-mean centred before entry into the model to improve interpretability of
their regression coefficients.
We made the decision to include depressive symptoms rather than anxiety symptoms in
the final model for three reasons. First, cross-sectional zero-order bivariate correlations
between the EPDS and the STAI at each wave ranged from .75 to .80 and so to avoid
redundancy in the model, only depressive symptoms were used. Second, zero-order bivariate
correlations between the EPDS and the FSFI were stronger than contemporaneous
correlations between the STAI and the FSFI, particularly in the postpartum. Finally, the
clinical focus of this study is depression.
Results
Sample Characteristics
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Characteristics of the sub-sample are presented in Table 1. On average, women were 31
years of age (SD = 4.50), ranging 19 through 48 years of age. Most women reported their
relationship status as either married or de facto (93%), had completed a post-secondary
qualification (94%), identified as Oceanian or European (90%) (Australian Bureau of
Statistics, 2016), and were nulliparous (95%). At birth, most women had their babies via
either normal or assisted vaginal delivery; the remainder delivered via cesarean section
(23%).
INSERT TABLE 1
Depression and Sexual Functioning During the Perinatal Period
Figure 1 displays the means and standard errors for FSFI scores for depressed and nondepressed women at each Wave. The figure shows that, overall, women’s FSFI score
declined from birth to six months postpartum, and recovered by 12 months postpartum. There
were significant, small to large effects between average FSFI scores in early pregnancy (F[1,
199] = 12.36, p = .001, Hedge’s g = .65) and third trimesters (F[1, 183] = 11.65, p = .001,
Hedge’s g = .83), and 6 months postpartum (Welch’s F[1, 44.09] = 4.80, p = .015, Hedge’s g
= .47). At 12 months postpartum, women in both groups reported higher FSFI scores
compared to six months postpartum and the difference between the average scores was not
significant (F[1, 181] = .26, p = .614, Hedge’s g = .11).
INSERT FIGURE 1
Other Covariates of Female Sexual Functioning During the Perinatal Period
The bivariate, zero-order correlations between covariates of female sexual function and
FSFI at each Wave of the study are shown in Table 2. Notably, there were no significant
associations between maternal age, parity, mode of delivery, and breastfeeding at 12 months,
with each of the four FSFI scores. During early pregnancy only, taking antidepressants and
higher levels of childhood trauma were each associated with significantly lower FSFI scores.
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Also, a depression diagnosis was associated with significantly higher reports of childhood
trauma. Finally, mothers who were continuing to breastfeed at six months reported
significantly lower contemporaneous FSFI scores; however, a depression diagnosis at
recruitment was not associated with breastfeeding at both six and 12 months post-partum.
The FSFI was significantly and negatively associated with the STAI at each cross-sectional
waves, such that higher state anxiety symptoms were associated with lower sexual
functioning.
INSERT TABLE 2
Depression, and Social Support on Female Sexual Functioning
For zero-order bivariate correlations between all variables in the latent growth curve
models, including univariate descriptive statistics, see Table 3. The average pattern of FSFI
during the perinatal period (refer to Figure 1) suggests a quadratic model of change would fit
the data better than a linear model of change. Compared to an intercept-only model (χ2 [211, 8]
= 66.57, p < .001, RMSEA = .19 [95% CI’s: .15, .23], SRMR = .16) and a linear slope model (χ2 [211,
5]

= 50.22, p < .001, RMSEA = .21 [95% CI’s: .16, .26], SRMR = .11), the quadratic model of change

was a better fit to the data (χ2 [211, 2] = 6.95, p = .031, RMSEA = .11 [95% CI’s: .03, .20], SRMR =
.07). The linear slope model was a significantly better fitting model than the intercept-only
model (Sattora-Bentler Scaled Δχ2 [Δd.f. = 3] = 14.19, p = .004), and the quadratic change
model, with error variance in the 12 month postpartum FSFI score constrained to zero, fit
significantly better than the linear slope model (Sattora-Bentler Scaled Δχ2 [Δd.f. = 3] = 41.00, p
< .001). In the quadratic model, all latent factors of change, except for linear slope variance,
were significant (InterceptM = 21.48, SE = .33, p < .001, Interceptvar = 17.47, SE = 3.14, p <
.001; LinearM = -1.69, SE = .24, p < .001, Linearvar = 3.95, SE = 2.14, p = .066; QuadraticM =
.24, SE = .04, p < .001, Quadraticvar = .13, SE = .06, p = .037). This suggests that, on average,
women in early pregnancy reported higher FSFI scores followed by an average significant
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decelerating reduction in functioning. However, significant variance around these growth
factors suggest varying FSFI starting points and rates of change within the sample.
We built upon the unconditional model by first adding only a depression diagnosis as
a time-invariant covariate to each of the three latent growth factors. This model fit the data
well, (χ2 [211, 3] = 7.41, p = .060, RMSEA = .08 [95% CI’s: .0, .16], SRMR = .05). In this model, a
depression diagnosis was associated with significantly lower than average starting FSFI
values (β = -.28, SE = .07, p < .001); however, as depression was not predictive of the linear
slope and quadratic growth factor, this model suggests that depressed women reported
significantly lower starting FSFI, and remain lower over the perinatal period. When we added
antidepressant use and childhood trauma as time-invariant covariates of the FSFI growth
factors, the model was a poorer fit to the data (χ2 [211, 7] = 21.86, p = .003, RMSEA = .10 [95%
CI’s: .05, .15],

SRMR = .06).

INSERT TABLE 3
Childhood trauma and Social Support
Childhood trauma was not related with any of the FSFI growth factors, suggesting that in the
context of a depression diagnosis and antidepressant use, childhood trauma does not account
for variability in the sexual functioning of women during the perinatal period. Women taking
antidepressants reported similar starting values of FSFI compared to the average; however,
antidepressant use was associated with a levelling of both the average negative slope and
average positive quadratic latent means. This suggests that for women taking antidepressants,
sexual functioning remains relatively stable across the perinatal period. Due to nonsignificance of childhood trauma, it was not included in subsequent modelling.
For the final model with time-varying covariates at third trimester, and six and 12
months postpartum, the model fit the data well (χ2 [209, 49] = 69.73, p = .027, RMSEA = .05 [95%
CI’s: .02, .07],

SRMR = .08). Figure 2 displays path coefficients for this final model. The pattern
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of significance for the time-invariant covariates, depression and antidepressant use, remained
the same as previous models; this suggests that net of the time-varying effects of depressive
symptoms and social support effectiveness, a depression diagnosis and antidepressant use
remained a significant predictor of change in FSFI over the perinatal period. At the third
trimester, only perceived task support from a partner was a significant predictor of
contemporaneous female sexual functioning, such that more perceived support with tasks was
associated with improved FSFI scores. .
INSERT FIGURE 2
At six months postpartum, only perceived emotional support from a partner was a
significant predictor of contemporaneous female sexual functioning, such that more
perceived emotional support was associated with improved FSFI scores. By 12 months
postpartum, both types of perceived support effectiveness did not significantly predict FSFI
scores. However, depressive symptoms was a significant predictor of female sexual
functioning, such that higher EPDS scores was associated with significantly lower FSFI
scores at 12 months.
Despite the contemporaneous effects of depressive symptoms and support
effectiveness, variance of the FSFI growth factors remained significant net of the timevarying covariates; this suggests that over and above the effects of depressive symptoms and
perceived support effectiveness, female sexual functioning continued to vary during the
perinatal period due to other variables not included in our model. Furthermore, the effect of a
depression diagnosis early in pregnancy remained a significant predictor of lower FSFI
starting values and change in FSFI during the perinatal period, even after controlling for
antidepressant use and net of the effects of the time-varying covariates.
In order to determine any impact of anxiety symptoms we also run the final model
replacing the time-covarying EPDS scores at Wave 2, Wave 4 and Wave 5 with the state
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subscale of the STAI. This version of the final model was a worse fit to the data (χ2 [209, 49]
= 80.06, p = .003, RMSEA = .05 [95% CI’s: .03, .08], SRMR = .09); further, anxiety
symptoms did not predict concurrent FSFI scores, including Wave 5 FSFI, which EPDS did
predict in the final model reported in Figure 2. With the STAI included, the pattern of effects
of support subscales on concurrent FSFI were unchanged
Discussion
This study reports on repeated measurement of both depression and sexual
functioning across pregnancy and the postpartum. A diagnosis of a depressive disorder
predicted lower female sexual functioning across the perinatal period with more women in
the range for sexual dysfunction than those without a depression diagnosis. Depressive
symptoms were also important, with higher than average depressive symptoms at 12 months
predicting lower sexual functioning. Against prediction, antidepressants were not associated
with an overall trend to lower sexual functioning across the perinatal period in this cohort.
Previous studies in adult women have shown an impact from both depression and
antidepressant use on domains of sexual functioning (Bakker et al., 2008, Cooper et al., 2007,
Jimenez-Solem et al., 2013). Our study builds on this with data to understand differences in
effect on sexual functioning specifically in the perinatal period and provides reassurance for
women who do require ongoing treatment for depression during the perinatal period (Bakker
et al., 2008, Cooper et al., 2007, Jimenez-Solem et al., 2013).
Within this study, we also attempted to account for key covariates relevant to
understanding sexual functioning across pregnancy and the postpartum in women with
depression. In addition to antidepressant use we also examined mode of delivery,
breastfeeding, childhood trauma and partner support as variables previously associated with a
a women’s sexual functioning but equally relevant to depression (Dias and Figueiredo, 2015,
Galbally et al., 2018, Heim et al., 2008, Saberi et al., 2017).
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For some women the choice of mode of delivery can be influenced by perceptions of
potential implications for their ongoing sexual functioning. Mode of delivery was not found
to be relevant and this included caesarean section. These findings help to clarify the
conflicting data on whether mode of delivery does impact on sexual functioning (Yeniel and
Petri, 2014). While previously, there have been both findings that caesarean section delivery
may be protective and a risk factor for poorer sexual functioning two recent studies have
shown no difference between delivery methods and sexual functioning by 6-12 months
postpartum (De Souza et al., 2015, Kahramanoglu et al., 2017, Yeniel and Petri, 2014). Our
data confirms these recent findings and can reassure women that delivery method is unlikely
to have a lasting impact on their sexual function.
While breastfeeding was shown to influence woman’s sexual functioning at 6 months
postpartum it was no longer relevant by 12 months postpartum. This was despite many of the
women within this cohort continuing to breastfeed (Galbally et al., 2018). Given the public
health significance of breastfeeding, this is also a reassuring finding.
Partner support was found to be an important factor in understanding sexual
functioning across the perinatal period. In particular, different types of partner support were
relevant to sexual functioning at different stages of the perinatal period. In late pregnancy,
partner support that took the form of assistance with tasks related most strongly to a woman’s
sexual functioning but by six months postpartum emotional support was the stronger
predictor of the woman’s sexual functioning. At 12 months postpartum, both task and
emotional support from the partner were important for female sexual functioning. Given the
significant emotional and lifestyle upheaval that a pregnancy and new baby bring to a couple,
it is not surprising that social support is an important aspect of a functioning and sexually
active relationship, including aspects of sexual behaviour and the enjoyment of sex. Clinical
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implications are that encouragement of effective social support from partners is likely to be
an important protective factor for women over the perinatal period.
One of our most interesting findings was in childhood trauma, including childhood
sexual abuse, which has previously been identified as a risk factor in for sexual dysfunction
(DiLillo, 2001). Previous studies have also found an increased likelihood of childhood trauma
in women with depression (Heim et al., 2008). However, the role of childhood trauma has not
previously been examined in the perinatal period in relation to depression and sexual
dysfunction. Of note we did find an association between childhood trauma and early
pregnancy sexual functioning but this was not sustained across the perinatal period. Future
research may clarify if this is relevant to the understanding of sexual functioning in the
perinatal period.
Limitations of this study include unavailability of data on perineal trauma. We also
did not collect any data from partners and given fathers/partners can develop depressive
symptoms in the postpartum period; this may be relevant to understanding a couple
functioning at this stage of life. A further limitation is the use of the FSFI while this is
regarded one of the most recommended measures for both its psychometrics and wide use;
there are only a limited number of studies in pregnancy. Furthermore, there have been
concerns about the statistical implications if women who report no sexual activity are
included in analysis. We have followed the recommendations in our final model but have also
reported on those excluded as a result (Meyer-Bahlburg and Dolezal, 2007).
Conclusion
Clinical care of women across pregnancy should always include a broad psychosocial
assessment and this cannot be simply the administration of a screening tool for depression
such as the EPDS. Instead, clinicians are encouraged to understand the range of
psychological and social factors associated with pregnancy and a new baby that may impact
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on a woman’s life. Included in this broad assessment is the quality of her close relationships
and psychosocial supports, which may also relate to her sexual functioning over the perinatal
period. This data can reassure women that if they do have either a vaginal birth or a caesarean
section it is unlikely to alter their sexual functioning and likewise that breastfeeding may only
impact their sexual life transiently. For woman who require treatment with antidepressants
this also does not appear from this data to further reduce sexual functioning beyond the
impact of pregnancy and the postpartum. This is reassuring for women and clinicians when
making the choice to commence or continue antidepressant treatment. However, depression
and ongoing symptoms of depression do reduce sexual functioning and increase the risk of
sexual dysfunction and this supports clinical recommendations across many countries that
highlight the importance of identification and management of perinatal depression (Howard
et al., 2014).
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Figure 1. Observed Female Sexual Functioning Index means and 95% confidence intervals of the mean (as error bars) during
the perinatal period for the No Depression and Depressed Groups.

Figure(s)

1

Figure 1. Final female sexual functioning conditional model with time-invariant and time-varying covariates during the perinatal period. Figure shows significant standardised (stdyx) regression paths
and unstandardised FSFI growth factor means and variance estimates. FSFI = Female Sexual Functioning Index, EPDS = Edinburgh Postnatal Depression Scale, SSET = Social Support Effectiveness
questionnaire – Task Support subscale, SSEE = Social Support Effectiveness questionnaire – Emotional Support subscale, 6m = Six months postpartum, 12m = 12 months postpartum, M = Mean,
Var = Variance.
*p < .05 **p < .01 ***p < .001.
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Table 1. Demographic Characteristics for Sample (N = 211)
n (%)
Depression Diagnosis at Recruitment
37 (17.5)
Antidepressant Use at Recruitment
32 (15.2)
Relationship status at Recruitment
Not currently in a relationship
5 (2.4)
Married
141 (66.9)
De facto
55 (26.2)
In a stable relationship but not living together
In a same sex partnership
Separated
Maternal Education
No further study since leaving school
Apprenticeship or traineeship
Certificate or Diploma
Bachelor’s degree or higher
Cultural Group/Ethnicity
Oceania/European
Aboriginal/Torres Strait Islander
Asian
Middle Eastern
Nulliparous
Vaginal Delivery (including assisted)

7 (3.3)
1 (1)
1 (1)
13 (6.2)
5 (2.4)
47 (22.3)
145 (68.7)
190 (90)
2 (1)
14 (6.6)
5 (2.4)
200 (94.8)
142 (67.3)

Table(s)

Table 3
Descriptive Statistics and Zero-order Bivariate Correlations Between all Variables in the Final Conditional Model (N = 211).
1
2
3
4
5
6
7
1
1. SCID-IV Depressiona
(W1)

8

9

10

11

12

13

14

15

16

.465**
1
2. Antidepressant Usea
(W1)
3. Childhood Trauma (log.273**
0.083
1
transformed)
-.242**
-.196**
-.158*
1
4. FSFI Score
(W1)
-.245**
-0.106
-0.069
.610**
1
5. FSFI Score
(W2)
-.180*
-0.039
-0.085
.436** .474**
1
6. FSFI Score
(W4)
-0.038
-0.108
-0.075
.400** .301**
.545**
1
7. FSFI Score
(W5)
.284**
.203**
.365**
-.196** -0.128
-0.111
-0.124
1
8. EPDS Score
(W2)
.187**
.149*
.219**
-.206** -0.147
-.296**
-.289** .526**
1
9. EPDS Score
(W4)
.253**
.184*
.351**
-0.109
-0.145
-.174*
-.317** .576**
.640**
1
10. EPDS Score
(W5)
-0.132
-0.06
-0.087
0.07
.180*
.201**
0.127
-.353** -.211** -0.142
1
11. SSET Score
(W2)
-.172*
-0.126
-0.152
0.075
0.115
.247**
.155*
-.311** -.375** -.294** .599**
1
12. SSET Score
(W4)
-.222**
-.144*
-.171*
.158*
0.121
.216**
.275** -.452** -.341** -.321** .495** .664**
1
13. SSET Score
(W5)
-0.101
-0.054
-0.108
0.068
0.083
.174*
0.057
-.395** -.273** -.190* .628** .457** .355**
1
14. SSEE Score
(W2)
-.142*
-0.083
-0.142
.153*
0.095
.303**
.178*
-.272** -.393** -.286** .481** .667** .482** .610**
1
15. SSEE Score
(W4)
-.262**
-.151*
-.224**
0.128
0.075
0.142
.257** -.354** -.337** -.351** .333** .466** .547** .517** .683**
1
16. SSEE Score
(W5)
.18
.15
3.48
21.35
20.62
18.92
20.96
6.19
5.58
6.32
13.97
12.44
12.67
15.08
14.10 13.22
Mean
.38
.36
.28
4.87
5.09
5.43
4.52
4.55
4.32
4.87
3.68
4.17
3.82
3.73
4.10
4.10
Standard Deviation
0-1
0-1
3.22 - 4.33
6 - 30
6 - 30
6 - 30
6 - 30
0 - 25
0 - 24
0 - 25
1 - 20
2 - 20
3 - 20
3 - 20
1 - 20 0 - 20
Range
Note. SCID-IV = Structured Clinical Interview for the DSM-IV; FSFI = Female Sexual Functioning Index; EPDS = Edinburgh Postnatal Depression Scale; SSET = Social Support Effectiveness scale, Task
Support subscale; SSEE = Social Support Effectiveness scale, Emotional Support subscale.
aCorrelations with SCID-IV Depression and Breastfeeding Cessation are point-biserial coefficients.
*p < .05 **p < .01.
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1
Table 2. Descriptive Statistics and Zero-order Bivariate Correlations Between Female Sexual Functioning Index Scores and Covariates (N = 211).
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
1. SCID-IV
Depressiona
(W1)
2. Antidepressant
Usea
(W1) .47***
3. Maternal Age
(W1) -.13
.02
a
4. Parity
.00
.20** .25***
5. Mode of
Deilverya
(W3)
.08
-.04
.04
-.12
a
6. Breastfeeding
(W4) -.10
-.14* .16* -.10 -.03
7. Breastfeedinga
(W5) -.12
-.10
.13
.06 -.07 .50***
8. Childhood
Trauma (logtransformed)
.27*** .08
-.11
-.11 .07
-.12
-.09
9. STAI
(W2) .27*** .20** -.02
.12 -.04
.02
-.12 .37***
10. STAI
(W4) .21** .14*
.07
.08 .05
-.01
-.10 .26** .57***
11. STAI
(W5) .37*** .23** -.03
.06 .01
-.04
-.16 .38*** .62*** 0.61***
12. Female Sexual
Functioning Score (W1) -.24** -.20*
.03
.06 .03
-.05
-.08 -.21** -.21** -.24**
-.17*
13. Female Sexual
Functioning Score (W2) -.25** -.11
.11
.08 .02
-.07
-.03
-.12
-.22**
-.18*
-.21** .61***
14. Female Sexual
Functioning Score (W4) -.18*
-.04
-.05
.11 .01 -.24** -.12
-.09
-.18* -.31*** -.22** .44*** .47***
15. Female Sexual
Functioning Score (W5) -.04
-.11
-.00
-.11 .03
.04
-.12
-.08
-0.16* -.33*** -.24** .40*** .30*** .55***
Mean
.18
.15
31.01 0.05 0.33 0.73 0.34 34.02 34.22
31.34
33.64 21.35 20.62 18.92 20.96
Standard Deviation
.38
.36
4.50 0.22 0.47 0.44 0.47 11.24 10.63
9.00
10.41
4.84
5.09
5.43
4.52
19 00025 20 20 8Range
0-1
0-1
48
1
1
0-1
1
76
73
20 - 57
65
6 - 30 6 - 30 6 - 29
30
FSFI, Female Sexual Functioning Index; STAI, State-Trait Anxiety Index.
a
Correlations with SCID-IV Depression, Parity, Mode of Delivery and Breastfeeding represent point-biserial coefficients.
*p < .05 **p < .01 ***p < .001.

Other Supplementary Material

Supplementary File
Excluded Participants
Of the 30 (12.2%) women who were excluded because they reported no sexual
activity at one or more waves, seven women (23.3%) reported no sexual activity at one wave,
12 (40.0%) women at two waves, 10 (33.3%) at three waves, and one (3.3%) women at all
four waves. Eleven women (37.9%) reported no attempt at sexual intercourse in early
pregnancy, 16 (53.3%) at third trimester, 26 (86.7%) at 6 months postpartum, and 12 (63.2%)
at 12 months. These excluded women were more likely to be from both the antidepressant use
(n = 11, 25.6%) and non-medicated depression groups (n = 7, 28.0%), compared to the
control groups (n = 12, 6.9%). Compared to the 211 women included in the analyses,
excluded women reported lower overall satisfaction with their sex life in early pregnancy
(Included: M = 3.72, SD = 1.12, Excluded: M = 3.18, SD = 1.16; F(1, 230) = 7.01, p = .019),
third trimester (Included: M = 3.36, SD = 1.17, Excluded: M = 2.67, SD = 1.35; F(1, 232) =
8.74, p = .003), and at 12 months postpartum (Included: M = 3.27, SD = 1.14, Excluded: M =
2.32, SD = 1.34; F(1, 210) = 11.82, p = .001). Excluded women also reported lower sexual
desire at 6 months postpartum only (Included: M = 2.32, SD = .94, Excluded: M = 1.83, SD =
.95; F(1, 230) = 6.96, p = .009). Further, excluded women reported higher anxiety symptoms
during early pregnancy (Included: M = 34.37, SD = 11.10, Excluded: M = 39.29, SD = 11.61;
F(1, 230) = 6.96, p = .009) and higher depressive symptoms at 6 months postpartum
(Included: M = 5.58, SD = 4.32, Excluded: M = 8.28, SD = 5.34; F(1, 230) = 6.96, p = .009),
compared to women included in the analyses.
However, there were no significant interaction effects on these FSFI subscales and the
mental health symptom measures between the inclusion/exclusion groups and recruitment
groups.

